Sarah A. Hayes

Sydney, NSW 2006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

Journal: Cancers

Published: January 15, 2024

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: July 14, 2021

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.

Journal: Journal of clinical medicine

Published: April 18, 2021

Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK.

Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK.

Journal: Molecular cancer therapeutics

Published: September 29, 2020

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.

Journal: The oncologist

Published: February 02, 2020

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer.

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 26, 2019

Correction to: The role of proteomics in the age of immunotherapies.

Correction to: The role of proteomics in the age of immunotherapies.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: October 30, 2018

The role of proteomics in the age of immunotherapies.

The role of proteomics in the age of immunotherapies.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: April 05, 2018

Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis.

Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis.

Journal: Asia-Pacific journal of clinical oncology

Published: September 24, 2017

Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.

Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.

Journal: Journal of breath research

Published: July 06, 2016

From mice to men: GEMMs as trial patients for new NSCLC therapies.

From mice to men: GEMMs as trial patients for new NSCLC therapies.

Journal: Seminars in cell & developmental biology

Published: March 31, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026